Clinical Trials on Gastroenteropancreatic Neuroendocrine Neoplasm
Total 107290 results
-
Amr Mohamed MDNovatek PharmaceuticalsActive, not recruitingNeuroendocrine Carcinoma | Gastroenteropancreatic Neuroendocrine Tumor | Gastroenteropancreatic Neuroendocrine Neoplasm | Mixed Neuroendocrine-Non Neuroendocrine NeoplasmUnited States
-
Grupo Espanol de Tumores NeuroendocrinosActive, not recruitingNeuroendocrine Tumors | Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine TumorSpain
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Gastroenteropancreatic Neuroendocrine TumorChina
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaboratorsRecruitingNeuroendocrine Tumors,GastroenteropancreaticTaiwan
-
University of IowaPatient-Centered Outcomes Research Institute; Medical University of South Carolina and other collaboratorsEnrolling by invitationNeuroendocrine Tumors | Neuroendocrine Carcinoma | Lung Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine TumorUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdvanced Gastroenteropancreatic Neuroendocrine Tumor
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Paul Scherrer Institute (PSI)RecruitingNeuroendocrine Neoplasia's (NENs) | Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)Switzerland
-
University Hospital, AntwerpErasmus Medical Center; ZonMw: The Netherlands Organisation for Health Research... and other collaboratorsRecruitingGastroenteropancreatic Neuroendocrine TumorNetherlands, Belgium
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedLung Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine TumorUnited States
-
Novartis PharmaceuticalsCompletedGastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic SystemGermany
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsFinland, Norway, Sweden, Denmark, Latvia, Lithuania, Estonia
-
IpsenCompletedGastro-Enteropancreatic Neuroendocrine TumorUnited States, Austria, Denmark
-
Advanced Accelerator ApplicationsActive, not recruitingNeuroendocrine TumorsUnited Kingdom, Portugal, Spain, France, United States
-
Jules Bordet InstituteCompletedGastroenteropancreatic Neuroendocrine TumorsBelgium
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
Peking UniversityNot yet recruiting
-
Wren Laboratories LLCActive, not recruitingNeuroendocrine Tumor | GastroenteropancreaticItaly
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsGermany, Austria
-
RayzeBio, Inc.Active, not recruitingNeuroendocrine Tumors | Carcinoid Tumor | Gastroenteropancreatic Neuroendocrine Tumor | Carcinoid | GEP-NET | Gastroenteropancreatic Neuroendocrine Tumor Disease | Pancreatic NETCanada, Spain, United States, Netherlands, Belgium, France, Brazil
-
Advanced Accelerator ApplicationsActive, not recruitingPheochromocytoma | Paraganglioma | Gastroenteropancreatic Neuroendocrine TumorsUnited States, Spain, France, Poland, United Kingdom
-
National Cancer Institute (NCI)RecruitingNeuroendocrine Tumors | Neuroendocrine Neoplasms | Gastroenteropancreatico TumorsUnited States
-
Grupo Espanol de Tumores NeuroendocrinosRecruitingGastroenteropancreatic Neuroendocrine TumorSpain
-
Stanford UniversityNovartis PharmaceuticalsRecruitingGastroenteropancreatic Neuroendocrine TumorUnited States
-
Asan Medical CenterCompletedNeuroendocrine Tumors | Neuroendocrine Carcinoma | Capecitabine | TemozolomideKorea, Republic of
-
IRCCS San RaffaeleRecruitingGastroenteropancreatic Neuroendocrine TumorItaly
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesTerminatedGastroenteropancreatic Neuroendocrine TumorChina
-
Advanced Accelerator ApplicationsActive, not recruitingGastroenteropancreatic Neuroendocrine TumorItaly
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorChina
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorUnited States
-
ITM Solucin GmbHRecruitingNeuroendocrine TumorsUnited States, United Kingdom, Australia, France, Italy, Netherlands, Spain, Germany, Sweden, India
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive GEP-NETKorea, Republic of
-
Assistance Publique - Hôpitaux de ParisRecruitingRadiotherapy | Gastroenteropancreatic Neuroendocrine TumorFrance
-
Nantes University HospitalCompletedPatients With Gastroenteropancreatic Neuroendocrine TumorsFrance
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownGastroenteropancreatic Neuroendocrine Tumor G3China
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumoursSweden
-
British Columbia Cancer AgencyWithdrawnNeuroendocrine Tumors | Carcinoid Tumor | Gastrinoma | Insulinoma | Vipoma | Gastroenteropancreatic Neuroendocrine Tumor | Pulmonary Carcinoid TumorCanada
-
University Hospital, BordeauxAdvanced Accelerator ApplicationsRecruitingNeuroendocrine Tumor | Liver Metastases | Neuroendocrine Gastroenteropancreatic TumourFrance
-
AbbVieTerminatedGlioblastoma | Medullary Thyroid Cancer | Malignant Melanoma | Other Solid Tumors | Large-Cell Neuroendocrine Carcinoma | Neuroendocrine Prostate Cancer | High Grade Gastroenteropancreatic Neuroendocrine Carcinoma | Other Neuroendocrine CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
University Hospital Inselspital, BerneUniversity Hospital, Basel, Switzerland; University of Lausanne Hospitals; University... and other collaboratorsTerminatedGastroenteropancreatic Neuroendocrine TumorsSwitzerland
-
Debiopharm International SAActive, not recruitingAcromegaly | GEP-NETUnited Kingdom, France, Spain, Italy, Poland, Denmark, Germany, Israel
-
Assistance Publique Hopitaux De MarseilleCompleted
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsUnited States
-
Advanced Accelerator ApplicationsCompletedGastroenteropancreatic Neuroendocrine TumorsUnited Kingdom, Italy, Netherlands, Poland
-
Duke UniversityMerck Sharp & Dohme LLC; IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsUnited States
-
Roswell Park Cancer InstituteNot yet recruitingMalignant Solid Neoplasm | Lung Neuroendocrine Neoplasm | Digestive System Neuroendocrine Neoplasm | Pancreatic Neuroendocrine NeoplasmUnited States
-
Phanes TherapeuticsRecruitingSmall Cell Lung Cancer (SCLC) | Large Cell Neuroendocrine Cancer (LCNEC) | Neuroendocrine Prostate Cancer (NEPC) | Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)United States
-
National Cancer Institute (NCI)RecruitingLocally Advanced Lung Neuroendocrine Neoplasm | Lung Neuroendocrine Neoplasm | Metastatic Lung Neuroendocrine Neoplasm | Recurrent Lung Neuroendocrine Neoplasm | Unresectable Lung Neuroendocrine Neoplasm | Advanced Lung Neuroendocrine Tumor | Functioning Lung Neuroendocrine Tumor | Lung Neuroendocrine... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingCarcinoid Tumor | Functioning Pancreatic Neuroendocrine Tumor | Intermediate Grade Lung Neuroendocrine Neoplasm | Locally Advanced Pancreatic Neuroendocrine Tumor | Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm | Low Grade Lung Neuroendocrine Neoplasm | Metastatic Digestive... and other conditionsUnited States
-
Translational Research in OncologyBayer; NovartisWithdrawnSoft Tissue Sarcoma | Small Cell Lung Carcinoma | Colorectal Neoplasms | Anal Squamous Cell Carcinoma | Malignant Pleural Mesothelioma | Castrate Resistant Prostate Cancer | Gastroenteropancreatic Neuroendocrine Neoplasm | Neuroendocrine Carcinoma of Prostate